Back to Agenda
Introducing the Roundtable Discussions
Session Chair(s)
Maria Vassileva, PhD
Chief Science and Regulatory Officer
DIA, United States
Based on the attendees’ topic preference, which will be collected during the registration process, the room will be separated into three sections – one for each of the three topics: 1) Master Protocols; 2) Innovative clinical Trial Design Methodology, and 3) Borrowing of Data. Once in their selected section of the room, attendees will join one of the pre-set large roundtables for the discussion. Each individual table will have 10 seats including a moderator. The DIA Team and Program Committee have prepared a list of questions for discussion on each topic. Table participants will be able to add on to the list during the roundtable discussion.
Have an account?